JNJ-3738
JNJ-3738 (Compound 148) is the inhibitor for CDK7 with a Ki of 21.75 nM. JNJ-3738 inhibits the proliferation of CDK7 WT expressing A549 with pIC50 of 7.37[1].
Product Specifications
CAS Number
[2796279-20-2]
UNSPSC
12352005
Target
CDK
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
C[C@@H]1C2=C(N3CCS(=O)(CC3)=O)N=CN=C2NC4=CC(C5CCN(C6CN(C6)C(C#CC)=O)CC5)=CC(C)=C4O1
Molecular Formula
C29H36N6O4S
Molecular Weight
564.70
References & Citations
[1]Stansfield I, et al., Tricyclic pyrimidines as cyclin-dependent kinase 7 (cdk7) inhibitors. WO2022136174
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
123793-ML650 100 µL
BAALC (Brain and Acute Leukemia Cytoplasmic Protein, FLJ12015) (MaxLight 650)
Ask
View Details